reSee.it - Related Video Feed

First, the mRNA is injected within lipid nanoparticles in your arm. It travels through every organ system, including the heart. There are two papers, one by Baumeyer and colleagues, one by Crosson and colleagues. Crosson found mRNA directly in the heart of deceased mRNA recipients. So we know it reaches the heart. Baumeyer found the spike protein directly in the heart in biopsies of patients with vaccine induced myocarditis. So we know the vaccine mRNA and lipid nanoparticles get into the heart, translate into spike proteins, so your cardiomyocytes begin to produce a toxic non human protein and your own body attacks the heart resulting in inflammation and cardiac scarring including micro scars which are undetectable with imaging. You can only detect it with a microscope, which is very disturbing. And so once you have this scarring, you're going to have cardiac electrical abnormalities, electrical conduction abnormalities, and your heart's not going to beat properly. Then when you go exercise, we found there's two triggers either during exercise or sports when there's exertion or during the morning waking hours of sleep. In these two periods of time, there's a surge in catecholamines including dopamine, norepinephrine, and epinephrine. And so during these times when you have this cardiac damage, you have this scarring, that's the trigger you do that leads to this vaccine induced cardiac arrest. And that's why we saw a lot of sudden deaths among athletes back in 2021.

Myocarditis, or heart damage, is more common than previously thought. Studies in the US military and Thailand show that around 20% of people who receive the COVID vaccine develop myocarditis, as confirmed by echocardiograms and other tests. This means that out of every 1 million vaccinated individuals, 200,000 will experience heart damage. Unfortunately, 50% of those with myocarditis will die within 5 years. This alarming increase in myocarditis cases is due to the cardiotoxic nature of the vaccine. This information comes from Dr. Cressel and Shoemaker in Toronto, Canada.

Speaker 1 discusses the progression of understanding around heart damage associated with this product, emphasizing key studies and their implications. He recalls that in 2022 German scientists tested and reported that heart damage seen in myocarditis patients corresponds to vaccine-triggered autoimmune reactions. They examined endomyocardial biopsies and observed that the cardiac detection of the spike protein and CD4+ T cell–dominated inflammation suggested a vaccine-triggered autoimmune process. He notes headlines that infections could cause more myocarditis than vaccination and cites a large Israeli population study from that year finding no increase in myocarditis or pericarditis among unvaccinated individuals, challenging the notion that vaccination is the sole driver. Speaker 1 then highlights a new study published in the American Heart Association journal Circulation, framing it as a major development not from fringe sources but from a prestigious, mainstream journal. He asserts that this study goes beyond epidemiology by demonstrating a mechanism. In an experimental model, mice were used to induce myocarditis-like cardiac damage; researchers then compared these findings to humans who had similar heart damage post-vaccination. They found that T cells from patients with acute myopericarditis recognize vaccine-encoded spike epitopes that are homologous to cardiac self proteins, indicating cross-reactivity where the immune system targets both the spike protein and cardiac proteins. Speaker 1 explains that the study measured functional responses to potassium channels (KV) and observed an expanded pattern of cytokine production in patients with mild pericarditis after mRNA vaccination, but not in patients with COVID-19 without vaccination. This expanded cytokine response mirrored what was seen in AMP (myopericarditis) mice and in autoimmune myocarditis, linking the clinical data with the animal model. He paraphrases the study’s plain-language takeaway: post-mRNA vaccine myopericarditis is driven by molecular mimicry, with the immune system failing to distinguish self from non-self in susceptible patients. The study further notes that vaccine distribution contributes to susceptibility; the widespread distribution of the vaccine allows the heart to be targeted, leading to cardiac-selective autoimmunity by “heart-homing imprinting.” Speaker 1 emphasizes the significance of the source, stating that the journal is not fringe: it is the Circulation journal, ranked third in its field with a cardiovascular-focused impact in the 99th percentile. The overall conclusion presented is that these findings provide a clear mechanism for post-vaccination myopericarditis and establish a direct link between vaccine-encoded spike epitopes and cardiac autoimmunity.

The discussion centers on new evidence regarding myocarditis and pericarditis in the context of mRNA vaccination. It cites earlier 2022 German research showing that heart damage seen in myocarditis cases after vaccination may be a vaccine-triggered autoimmune reaction. The study analyzed endomyocardial biopsy samples and found that the cardiac tissue’s spike protein detection and CD4+ T cell–dominated inflammation suggested an autoimmune mechanism linking the vaccine to heart damage. This was contrasted with an Israel-based population study of hundreds of thousands of unvaccinated individuals that reported no increase in myocarditis or pericarditis incidence, highlighting a discrepancy with the vaccine-triggered autoimmune hypothesis. The center of the new claim is a study published in Circulation by the American Heart Association. The speakers emphasize the credibility of Circulation as a top cardiovascular journal. The study used an experimental mouse model to induce cardiac damage and then examined humans with similar heart damage after vaccination to see if the same mechanism applied. They report that T cells from patients with acute myopericarditis recognize vaccine-encoded spike epitopes that are homologous to cardiac self-proteins. In other words, the immune cells targeting the spike protein may also attack cardiac proteins due to molecular similarity. Further details from the study indicate that, in patients with mild pericarditis after mRNA vaccination (but not in those with COVID-19), there was an expanded pattern of cytokine production similar to that observed in myopericarditis–affected mice and in autoimmune myocarditis. The takeaway provided in plain language is that post-mRNA vaccine myopericarditis is driven by molecular mimicry, causing the immune system to fail to distinguish self from non-self in susceptible patients. The susceptibility is described as being influenced by the widespread distribution of the vaccine, which purportedly leads to heart-homing imprinting and a heart-targeted autoimmune response. The speakers stress that this journal is not fringe and highlight its high impact in cardiovascular medicine. They conclude that the data collectively suggest a mechanism by which the vaccine could provoke cardiac autoimmunity, with implications for clinical communication and understanding of post-vaccination myocarditis.

A recent study from Switzerland found that 1 in 35 people who received the Moderna booster shot experienced heart injury. Researchers hypothesized that many cases went unnoticed due to lack of symptoms. They tested for heart injury by measuring levels of cardiac troponin t in the blood, which indicates heart damage. This study aimed to uncover the true prevalence of vaccine-associated heart injury post mRNA booster vaccination.

A recent study suggests a potential link between mRNA COVID-19 vaccines and sudden cardiac deaths. Researchers found that when Pfizer and Moderna vaccines were applied directly to heart muscle cells, abnormal function and electrical currents occurred within 48 hours, indicating cardiac toxicity. Another study showed that mRNA was physically stuck in the hearts of individuals who died after vaccination. Additionally, a large study found abnormal heart scans in those who received the vaccine, with virtually everyone showing abnormal results. Even individuals with inflammation or higher mRNA doses had worse cardiac findings. This suggests the possibility of cardiac dysfunction or arrest without myocarditis. The information challenges the official narrative and raises concerns.

Myocarditis was most common in young men, with rates as high as 1 in 5000 vaccine recipients. The condition was mostly mild but could have lasting effects. Natural immunity from prior COVID infection was shown to be more protective than two vaccine doses. Combining prior infection with vaccination provided even better protection. The speaker did not take a booster shot.

The discussion centers on evidence linking myocarditis and pericarditis to mRNA vaccination and the proposed mechanism behind it. It references a 2022 German study reporting that endomyocardial biopsy data from people with myocarditis showed cardiac detection of the spike protein and CD4+ T cell–dominated inflammation, suggesting a vaccine-triggered autoimmune reaction. The presenters note headlines at the time comparing myocarditis risk to infection, with claims that infection causes more myocarditis, and remind that vaccines were said not to stop transmission. They then cite a large Israeli population study from the same year involving subjects not vaccinated against SARS-CoV-2, which found no increase in the incidence of myocarditis or pericarditis, implying no observed vaccine-related signal in that cohort. Attention shifts to a more recent study published in Circulation by the American Heart Association, described as a high-impact, non-fringe journal, indicating a clearer mechanism has been demonstrated. The study described used an experimental mouse model to induce cardiac damage and then compared it to human cases with heart damage following vaccination. It states that T cells from patients with acute myocarditis or myopericarditis recognize vaccine-encoded spike epitopes that are homologous to cardiac self proteins, meaning the immune response to the spike protein can cross-react with heart tissues. The researchers further report that functional responses to potassium channels in patients with mild pericarditis after mRNA vaccination, but not in patients with COVID-19, showed an expanded pattern of cytokine production similar to that observed in myopericarditis mice and in autoimmune myocarditis. In plain terms, the summary of their takeaway is that post-mRNA vaccine myopericarditis is driven by molecular mimicry: the immune system cannot distinguish self from non-self, leading to an autoimmune attack on heart tissue in susceptible patients. The distribution of the vaccine (its widespread dissemination) is cited as a factor that makes patients susceptible by promoting heart-homing imprinting, effectively creating an anti-heart autoimmune response. The speakers emphasize that this Circulation article is a top-tier source, underscoring that the mechanism has been demonstrated with both animal models and human pathology, supporting the claim that the phenomenon has a defined immunological basis.

The speaker discusses a significant increase in myocarditis cases post-vaccination, with studies showing abnormal cardiac scans in vaccinated individuals. They suggest a potential link between mRNA vaccines and heart inflammation, emphasizing the need for long-term monitoring. Research indicates that mRNA and spike proteins can cause myocarditis, posing a concern for all mRNA products. The heart appears to be a vulnerable target due to various factors.

One in thirty-five recipients of the booster vaccine had vaccine-associated myocardial injury. This level of adverse reaction is described as off the scale in healthcare. The speaker suggests that promoting the vaccine in places like New Zealand is unethical. The speaker believes this risk level would only be acceptable if the alternative was certain death, and otherwise, it is complete madness.

The FDA is adding a warning to the COVID vaccine that it causes myocarditis, something that has been reported on and that many people have raised alarms about. It was found in preclinical studies, which had to be paused due to signals. The FDA release headline states the warning is about heart side effects for young males. The FDA press release says the warning has to go into the vaccine insert. A study found that at a medium follow-up of approximately five months post vaccination, persistence of abnormal cardiac magnetic resonance imaging findings, a marker for myocardial injury, was common. The clinical and prognostic significance of these findings is not known. Damage to heart muscles means they do not reproduce, which is potentially problematic.

A cardiologist provides an update on the Pfizer and Moderna vaccines. Studies have shown that the vaccines can cause direct harm to heart muscle cells, abnormal heart contractions, and abnormal electrical activity. Messenger RNA from the vaccines has been found in the human heart and circulating in the blood for up to 28 days. The spike protein produced by the messenger RNA has also been detected in the blood for up to 6 months. The spike protein is dangerous to cells, tissues, and organs in the body. The messenger RNA used in the vaccines has been modified and is synthetic. Autopsy studies have shown that the vaccine can cause myocarditis and cardiac damage. A basketball player who received the vaccine suffered a cardiac arrest and died two years later.

A speaker describes a multi-site study involving scientists in Houston, New York City, and Oxford, England. They analyzed data from 7,000 patients, of which 1,000 were PET-scanned for illnesses unrelated to myocarditis or heart disease; the heart was still examined as part of the PET scans. From the 1,000 patients, two-thirds were vaccinated and one-third were unvaccinated, forming the study group for comparison. According to the account, the two-thirds vaccinated subgroup (about 700 people) showed the heart working 46 percent harder for six to seven months after receiving the double vaccine dose. The speaker notes that as a cardiologist, a heart working 15 percent harder under any circumstance or drug would be alarming, implying that a sustained 46–50 percent increase is dangerous. The vaccinated group allegedly experienced 18,000,000 heartbeats with the heart exerting near-50 percent more effort than normal during this period. In contrast, the non-vaccinated group who were PET-scanned for other reasons reportedly did not show an increase in FDG uptake or myocardial effort; their heart activity remained where it should be, with no extra strain observed. The speaker asserts that this finding constitutes clear evidence that vaccination causes significant long-term strain on the heart in this cohort, stating, “There are folks without myocarditis. But they had myocardial effort. Myocardial effort up 46 to 50%.” The conclusion drawn is that vaccines are causing substantial and prolonged heart workload. A reference is made to Nakahara as a key paper relevant to the discussion, described as “a very, very important paper.” The discussion suggests that the Nakahara findings, along with the described PET-scan data, constitute a strong argument about cardiac effects following vaccination, framing the vaccination strategy as potentially overlooking this cardiac impact. Note: The summary preserves the specific figures and statements as presented in the transcript, including the claim that the vaccinated group showed a 46–50% increase in myocardial effort for about six months post-vaccination and that the non-vaccinated group did not demonstrate such an increase.

A recent study from Switzerland found that 1 in 35 individuals who received the Moderna booster shot experienced vaccine-associated heart injury. The researchers hypothesized that this type of injury was more common than previously believed due to the lack of symptoms or mild symptoms. To investigate this, the researchers tested the blood of participants instead of relying solely on self-reported symptoms. They defined heart injury as a significant increase in high sensitivity cardiac troponin levels on the third day after vaccination, without any other apparent cause. The use of the troponin test was chosen because it is a reliable indicator of heart damage.

Regulators need to pay attention to the findings of a study conducted in Switzerland on Moderna booster vaccines. The study revealed that 5.1% of participants who received the booster vaccine experienced increased troponin levels, indicating damage to heart cells. Additionally, 2.8% of participants had vaccine-associated myocardial injury. The study, published in the European Journal of Heart Failure, was a prospective active surveillance study and independent of the vaccine manufacturers. The aim was to investigate the incidence and mechanism of oligosymptomatic myocardial injury. These results highlight significant risks associated with the booster vaccine and raise concerns about its promotion in certain countries.

The COVID-19 vaccine can induce cardiac arrest. mRNA injections travel to all organ systems, including the heart, causing cardiomyocytes to produce spike proteins, which are also found circulating in the bloodstream and can reach the heart. The largest COVID-19 vaccine safety study, involving 99 million people, showed a 600% increased risk of myocarditis after mRNA injections. The trigger for cardiac arrest is usually in the waking morning hours of sleep, 3AM to 6AM, or during sports or exercise when there's a surge in catecholamines. Cardiac events are known to occur during sleep when catecholamines rise and during exercise when oxygen demands and catecholamines increase. This is not supposed to be seen in young healthy adults, but rather in those with intrinsic heart disease or the very elderly.

The government has noted an increase in excess deaths in England and Wales, mainly due to heart disease and flu. Some believe that COVID vaccines may be contributing to heart conditions. Dr. Thomas Levy estimates that 2.8% of people who received COVID vaccines have suffered heart injuries, with potentially over 100 million Americans affected. This damage may be detectable with a troponin test.

Myocarditis, or heart inflammation, is more common than previously believed. Recent studies show that around 20% of individuals who received the COVID vaccine experience myocarditis, as confirmed by echocardiograms and other tests. This means that out of every 1 million vaccinated people, around 200,000 will have evidence of heart damage. Unfortunately, those who develop myocarditis have a 50% chance of surviving only 5 years. This alarming increase in myocarditis cases is due to the cardiotoxic nature of the vaccine. These facts, shared by Dr. Cussell and Shoemaker from Toronto, highlight the concerning impact of the vaccine on heart health.

In England and Wales, heart disease is a significant factor in COVID-19 deaths. Some believe vaccines may worsen heart conditions, with Dr. Thomas Levy estimating 2.8% of people receiving COVID injections experience heart injury. He suggests over 100 million Americans may have some level of heart damage from the vaccines, excluding myocarditis.

Before COVID-19, I only encountered two cases of myocarditis in my entire career as a cardiologist. However, now I see two cases per day in the clinic. We have learned that COVID-19 can cause myocarditis, and various organizations conducted screening programs in 2020. These programs found a few cases that met the definition of myocarditis, but none were serious or resulted in hospitalizations or deaths. After the introduction of vaccines, regulatory agencies acknowledged that the vaccines can cause COVID-19 vaccine-induced myocarditis, which can be fatal. It's important for people to understand that there is a risk associated with every vaccine shot they take.

As a cardiologist, the speaker states their role is to fight disease, preserve life, and do no harm. The topic is myocarditis or heart damage from the COVID-19 vaccines. The speaker claims to have examined thousands of patients with this problem, whereas before the pandemic, they state they only had two patients ever with this condition. The speaker references a New England Journal of Medicine paper from Washington University in St. Louis, August 18, 2021, where a 42-year-old man died three days after taking Moderna. They also cite a case from Korea by Choi and colleagues, where a younger man died within eight hours of being in the hospital after Pfizer. The speaker examined images from the Korean case and states the heart appeared "fried with inflammation" and "destroyed." The speaker concludes these cases should have gotten everyone's attention.

Vaccination introduces mRNA into the bloodstream, which is taken up by major organs, including the heart. This process leads to the production of spike protein in heart muscle cells, resulting in inflammation and an increased risk of myocarditis. A large study indicated a 500% higher risk of myocarditis following COVID vaccination. Symptoms of myocarditis can be triggered during early morning hours (3 AM to 6 AM) when catecholamines like dopamine and epinephrine surge, as well as during exercise. These triggers can lead to serious heart issues, including ventricular tachycardia and sudden death.

In October 2020, the FDA mentioned that myocarditis could be a result of the COVID vaccines. In June 2021, the FDA confirmed that the vaccines can cause heart inflammation. Prior to COVID, patients with myocarditis were advised not to exercise due to the risk of cardiac arrest. Now, there are 800 peer-reviewed papers on COVID vaccine-induced myocarditis. Two studies showed a 2.5% rate of heart damage after receiving the second or third vaccine dose. When heart damage occurs, there can be variations in electrical conduction, leading to reentry and fast heart rhythms like ventricular tachycardia. This can progress to ventricular fibrillation, which is fatal. A recent study confirmed that vaccine-induced myocarditis is always fatal.

First, the mRNA is injected within lipid nanoparticles in your arm. It travels through every organ system, including the heart. Crosson found mRNA directly in the heart of deceased mRNA recipients. So we know it reaches the heart. Baumeyer found the spike protein directly in the heart in biopsies of patients with vaccine induced myocarditis. So we know the vaccine mRNA and lipid nanoparticles get into the heart, translate into spike proteins, so your cardiomyocytes begin to produce a toxic non human protein and your own body attacks the heart resulting in inflammation and cardiac scarring including micro scars which are undetectable with imaging. And so once you have this scarring, you're going to have cardiac electrical abnormalities, electrical conduction abnormalities, and your heart's not going to beat properly. And that's why we saw a lot of sudden deaths among athletes back in 2021.

The harm caused by this vaccine isn't from the spike protein itself, but from the immune system's misidentification of the heart. The body attacks the heart because the spike protein alters its genetic image, making it seem foreign. This is fundamental immunology. The vaccine's creators were aware of this effect. The vaccine's toxicity and ability to manipulate the immune system to cause harm, whether slowly or rapidly, point to a deliberate design. This level of damage couldn't be accidental.